ESR1 and breast cancer: Likewise, disruption of melatonin rhythms via exposure to ALAN lead to metastatic developments in the lung, liver, and brain of athymic nude rats with ERα+ MCF-7 breast cancer xenografts, whereas administration of exogenous melatonin reduced tumor development and metastatic lesions [158].